Literature DB >> 17496268

Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the rat.

John W Newman1, George A Kaysen, Bruce D Hammock, Gregory C Shearer.   

Abstract

We previously established that proteinuria alters the apolipoprotein content of lipoproteins. This study was conducted to establish whether proteinuria also alters the concentrations of oxidized lipids within lipoprotein density fractions. To this end, we induced passive Heymann nephritis in Sprague Dawley rats and measured an array of alkaline-stable oxylipids in VLDL, LDL, and HDL particles. Proteinuria increased the total oxylipid amounts in the HDL and VLDL fractions. More importantly, these levels were increased when expressed per unit lipoprotein protein, indicating that the oxidized lipid load per particle was increased. Epoxides and diols increased approximately 2-fold in HDL and approximately 5-fold in VLDL, whereas LDL showed approximately 2-fold decreases. The hydroxyeicosatetraenoic acids and hydroxyoctadecadienoic acids (HODEs) increased >4-fold in HDL and >20-fold in VLDL, whereas LDL showed approximately 2-fold decreases in the HODEs. Therefore, nephrotic syndrome alters the lipoprotein oxylipid composition independently of an increase in total lipoprotein levels. These proteinuria-induced changes may be associated with the cardiovascular risk of lipoprotein oxidation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17496268     DOI: 10.1194/jlr.M700146-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  24 in total

Review 1.  Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.

Authors:  Valentina Kon; Haichun Yang; Sergio Fazio
Journal:  Arch Med Res       Date:  2015-05-23       Impact factor: 2.235

Review 2.  Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials.

Authors:  Chi-Chih Hung; Jer-Chia Tsai; Hung-Tien Kuo; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Rev Diabet Stud       Date:  2013-08-10

3.  Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations.

Authors:  Angela M Zivkovic; Jun Yang; Katrin Georgi; Christine Hegedus; Malin L Nording; Aifric O'Sullivan; J Bruce German; Ronald J Hogg; Robert H Weiss; Curt Bay; Bruce D Hammock
Journal:  Metabolomics       Date:  2012-12       Impact factor: 4.290

4.  Quantitative determination of esterified eicosanoids and related oxygenated metabolites after base hydrolysis.

Authors:  Oswald Quehenberger; Signe Dahlberg-Wright; Jiang Jiang; Aaron M Armando; Edward A Dennis
Journal:  J Lipid Res       Date:  2018-10-15       Impact factor: 5.922

5.  Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation.

Authors:  Limin Wang; Rajan Gill; Theresa L Pedersen; Laura J Higgins; John W Newman; John C Rutledge
Journal:  J Lipid Res       Date:  2008-09-23       Impact factor: 5.922

6.  Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteins.

Authors:  Gregory C Shearer; John W Newman
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-11-29       Impact factor: 4.006

7.  Heparin, lipoproteins, and oxygenated fatty acids in blood: a cautionary note.

Authors:  T L Goodfriend; T L Pedersen; R J Grekin; B D Hammock; D L Ball; A Vollmer
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2007-11-26       Impact factor: 4.006

8.  Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain.

Authors:  Tricia M Miller; Mark K Donnelly; Elizabeth A Crago; Dana M Roman; Paula R Sherwood; Michael B Horowitz; Samuel M Poloyac
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-10-14       Impact factor: 3.205

Review 9.  Impact of circulating esterified eicosanoids and other oxylipins on endothelial function.

Authors:  Gregory C Shearer; John W Newman
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113

10.  Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research.

Authors:  Augustin Scalbert; Lorraine Brennan; Oliver Fiehn; Thomas Hankemeier; Bruce S Kristal; Ben van Ommen; Estelle Pujos-Guillot; Elwin Verheij; David Wishart; Suzan Wopereis
Journal:  Metabolomics       Date:  2009-06-12       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.